Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory T‐cell development in the tumor microenvironment
Kota Itahashi, Takuma Irie, Hiroyoshi Nishikawa
European Journal of Immunology (2022) Vol. 52, Iss. 8, pp. 1216-1227
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 103
Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer
Andrew S. Mikhail, Robert Morhard, Michal Mauda‐Havakuk, et al.
Advanced Drug Delivery Reviews (2023) Vol. 202, pp. 115083-115083
Open Access | Times Cited: 57
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 51
TIGIT, a novel immune checkpoint therapy for melanoma
Wei Tang, Jun Chen, Tianlong Ji, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 46
The dynamic shifts of IL-10-producing Th17 and IL-17-producing Treg in health and disease: a crosstalk between ancient "Yin-Yang" theory and modern immunology
Huantian Cui, Ning Wang, Hanzhou Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages
Takahiko Sato, Daisuke Sugiyama, Jun Koseki, et al.
JCI Insight (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43
Mingxiao Yin, Jingwen Dong, Cuicui Sun, et al.
Advanced Science (2023) Vol. 10, Iss. 13
Open Access | Times Cited: 25
Dissecting the roles and clinical potential of YY1 in the tumor microenvironment
MengNa Li, Jianxia Wei, Changning Xue, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 25
USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1
Zean Kuang, Xiaojia Liu, Na Zhang, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 10, pp. 2249-2264
Open Access | Times Cited: 23
Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy
Q. Chen, XUEJUN GUO, Wenxue Ma
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 1, pp. 49-60
Open Access | Times Cited: 23
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
Peng Ouyang, Lijuan Wang, Jianlong Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Fibroblast activation protein promotes progression of hepatocellular carcinoma via regulating the immunity
Xiangcheng Wang, Ruilong Niu, Hao Yang, et al.
Cell Biology International (2024) Vol. 48, Iss. 5, pp. 577-593
Open Access | Times Cited: 6
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
An inflammation-related subtype classification for analyzing tumor microenvironment and clinical prognosis in colorectal cancer
Jun‐Peng Pei, Yuye Gao, Aiwen Wu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences
Shahin Soltani, Ameneh Arabi, Kristine Mann, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 468-468
Open Access
The role of the tumor microenvironment and inflammatory pathways in driving drug resistance in gastric cancer: A systematic review and meta-analysis
F. Albano, Francesco Severini, Giovanni Calice, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167821-167821
Open Access
CD226 identifies functional CD8+T cells in the tumor microenvironment and predicts a better outcome for human gastric cancer
Hao Huang, Ziyi Huang, Junwei Ge, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 12
CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response
Belinda Palermo, Ornella Franzese, Giuseppe Frisullo, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 12
The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
Anna Koerner, Ryan H. Moy, Sandra Ryeom, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4114-4114
Open Access | Times Cited: 11
Significance of regulatory T cells in cancer immunology and immunotherapy
Daisuke Sugiyama, Kunihiko Hinohara, Hiroyoshi Nishikawa
Experimental Dermatology (2022) Vol. 32, Iss. 3, pp. 256-263
Open Access | Times Cited: 14
Vascular endothelial growth factor inhibitors promote antitumor responses via tumor microenvironment immunosuppression in advanced colorectal cancer
Yuki Hamada, Kiyonori Tanoue, Yoshiaki Kita, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 58, Iss. 9, pp. 1009-1020
Closed Access | Times Cited: 8
Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer
Daiki Ikarashi, Shigehisa Kitano, Takashi Tsuyukubo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Discovery, biosynthesis, organic synthesis, and bioactivities of meroterpenoids from Rhododendron species
Yi Deng, Gui-Hu Lu, Jingyang Xu, et al.
Phytochemistry (2024) Vol. 222, pp. 114089-114089
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top